Intraoperative changes in blood lactate levels are associated with worse short-term outcomes after cardiac surgery with cardiopulmonary bypass.


Journal

Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 30 6 2019
medline: 24 6 2020
entrez: 29 6 2019
Statut: ppublish

Résumé

A high perioperative blood lactate level has been reported to be associated with poor outcomes after cardiac surgery. More than isolated peaks of lactate values, it should be more interesting to take into account changes in intraoperative blood lactate level (∆Lact). This large-scale retrospective study evaluated the relationship between ∆Lact and overall intensive care unit morbidity and 30-day all-cause mortality. Perioperative data from consecutive patients undergoing on-pump cardiac surgery between September 2010 and June 2016 were retrospectively analysed through our institutional database including clinical, transfusion and laboratory test results implemented prospectively by physicians. Blood lactate levels were initially measured after induction of anaesthesia (baseline) and periodically during the surgery. The ∆Lact was defined as the difference between the highest intraoperative blood lactate and the baseline lactate level and offered the opportunity to stratify patients into four subgroups: ⩽0, 0.1-0.9, 1-1.9 and ⩾2 mmol L From the 7,795 patients found eligible during the study period, 7,447 patients were analysed. The median ∆Lact of our patients was 0.6 (0.3-1) mmol L Our results suggest that ∆Lact is associated with poor short-term outcomes in adult cardiac surgical patients.

Sections du résumé

BACKGROUND
A high perioperative blood lactate level has been reported to be associated with poor outcomes after cardiac surgery. More than isolated peaks of lactate values, it should be more interesting to take into account changes in intraoperative blood lactate level (∆Lact). This large-scale retrospective study evaluated the relationship between ∆Lact and overall intensive care unit morbidity and 30-day all-cause mortality.
METHODS
Perioperative data from consecutive patients undergoing on-pump cardiac surgery between September 2010 and June 2016 were retrospectively analysed through our institutional database including clinical, transfusion and laboratory test results implemented prospectively by physicians. Blood lactate levels were initially measured after induction of anaesthesia (baseline) and periodically during the surgery. The ∆Lact was defined as the difference between the highest intraoperative blood lactate and the baseline lactate level and offered the opportunity to stratify patients into four subgroups: ⩽0, 0.1-0.9, 1-1.9 and ⩾2 mmol L
RESULTS
From the 7,795 patients found eligible during the study period, 7,447 patients were analysed. The median ∆Lact of our patients was 0.6 (0.3-1) mmol L
CONCLUSION
Our results suggest that ∆Lact is associated with poor short-term outcomes in adult cardiac surgical patients.

Identifiants

pubmed: 31250726
doi: 10.1177/0267659119855857
doi:

Substances chimiques

Lactic Acid 33X04XA5AT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

640-650

Auteurs

Benoit Duval (B)

Department of Anaesthesia and Critical Care, Magellan Medico-Surgical Centre, CHU Bordeaux, Bordeaux, France.
INSERM, UMR 1034, Biology of Cardiovascular Diseases, University of Bordeaux, Pessac, France.

Thibaud Besnard (T)

Department of Anaesthesia and Critical Care, Magellan Medico-Surgical Centre, CHU Bordeaux, Bordeaux, France.
INSERM, UMR 1034, Biology of Cardiovascular Diseases, University of Bordeaux, Pessac, France.

Stefano Mion (S)

Department of Anaesthesia and Critical Care, Magellan Medico-Surgical Centre, CHU Bordeaux, Bordeaux, France.
INSERM, UMR 1034, Biology of Cardiovascular Diseases, University of Bordeaux, Pessac, France.

Sébastien Leuillet (S)

Biofortis Mérieux NutriSciences, Saint-Herblain, France.

Olivier Jecker (O)

Department of Technical Engineering, CHU Bordeaux, Bordeaux, France.

Louis Labrousse (L)

Department of Cardiovascular Surgery, Haut-Leveque Hospital, CHU Bordeaux, Bordeaux, France.

Alain Rémy (A)

Department of Anaesthesia and Critical Care, Magellan Medico-Surgical Centre, CHU Bordeaux, Bordeaux, France.

Cedrick Zaouter (C)

Department of Anaesthesia and Critical Care, Magellan Medico-Surgical Centre, CHU Bordeaux, Bordeaux, France.

Alexandre Ouattara (A)

Department of Anaesthesia and Critical Care, Magellan Medico-Surgical Centre, CHU Bordeaux, Bordeaux, France.
INSERM, UMR 1034, Biology of Cardiovascular Diseases, University of Bordeaux, Pessac, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH